Article
Phage therapy in the Covid-19 era: Advantages over antibiotics
1 Jan 2022
Abstract excerpt
Today, the entire world is battling to contain the spread of COVID-19. Massive efforts are being made to find a therapeutic solution in the shortest possible time. However, the research community is becoming increasingly concerned about taking a shortsighted strategy without contemplating the long-term consequences. For example, It has been reported that only 8.4% of total COVID-19 patients develop a secondary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
